Search ARM

Publications & Presentations


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.

Highlights

Recent Webinars

MOST RECENT WEBINAR
April 2020

FDA Clinical Trial Guidance During COVID-19

This webinar features FDA representatives Tejashri Purohit-Sheth and Ilan Irony from the Office of Tissues and Advanced Therapies, CBER, as they discuss the effect of COVID-19 on cell and gene therapy clinical trials. Discussion topics include assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic.

April 7, 2020
September 19, 2019

Recent Publications

MOST RECENT PUBLICATION
May 2020
Article

Creating A Roadmap For The Development And Manufacture Of Gene Therapies

February 28, 2020
Commentary
January 31, 2020
Journal Article

Recent Presentations

MOST RECENT PRESENTATION
May 2020

Valuing Transformative Therapies: ASGCT 2020

Virtual

Janet Lambert, CEO, ARM

The presentation, which provides an overview on value demonstration for cell and gene therapies, cites information from ARM’s library of original policy analyses, including:

February 27, 2020

Landscape and Evolution of the Cell & Gene Therapy Marketplace: Public Policy Considerations – IO360

New York City
Download Presentation  
February 26, 2020

CAR-TCR Europe 2020: ATMP Market Access

London
Download Presentation  

Recently Submitted Comments, Letters, Statements

March 2020

December 2019

November 2019